Squaric Acid-Coumarin-Chlorambucil: Photoresponsive Single-Component Fluorescent Organic Nanoconjugates for Self-Monitored Therapeutics
Source abstract
Abstract
In this paper, we have developed photoresponsive fluorescent organic nanoconjugates based on a single-component system for effective cancer treatment by a synergistic combination of photodynamic therapy (PDT) and chemotherapy. Our single-component system was synthesized by coupling the squaric acid and the coumarin-chlorambucil conjugate. Next, multifunctional squaric acid-coumarin-chlorambucil (Sq-Cou-Cbl) nanoconjugates were prepared by “simple reprecipitation technique”. The unique properties of the newly designed Sq-Cou-Cbl nanoconjugates are (i) a phototrigger for controlled anticancer drug (chlorambucil) release and a photosensitizer for PDT upon visible light irradiation (ii) cellular imaging and self-monitoring of the drug release by a noninvasive fluorescent technique and (iii) PDT activity of the released photoproduct thereby resulting in the improved therapeutic efficiency. Further, in vitro studies showed that Sq-Cou-Cbl nanoconjugates exhibited an enhanced anticancer activity by synergistic cytotoxic effect of PDT and chemotherapy on HeLa cells.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Luminescence and Fluorescent Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (39)
Show source-provided references
1. 10.1002/adma.20170632010.1002/adma.201706320 ↗
2. 10.4155/tde.10.1310.4155/tde.10.13 ↗
3. 10.1021/acsami.8b0111410.1021/acsami.8b01114 ↗
4. 10.1016/j.biomaterials.2016.08.01610.1016/j.biomaterials.2016.08.016 ↗
5. 10.1021/cm504566f10.1021/cm504566f ↗
6. 10.3390/cancers302259710.3390/cancers3022597 ↗
7. 10.1016/j.jconrel.2018.02.00110.1016/j.jconrel.2018.02.001 ↗
8. 10.1002/adma.20170483310.1002/adma.201704833 ↗
9. 10.1021/acsami.8b0826910.1021/acsami.8b08269 ↗
10. 10.1039/C8SC02305K10.1039/C8SC02305K ↗
11. 10.1021/acs.biomac.8b0060710.1021/acs.biomac.8b00607 ↗
12. 10.1021/acsanm.8b0057210.1021/acsanm.8b00572 ↗
13. 10.1021/acsami.5b1119710.1021/acsami.5b11197 ↗
14. 10.1002/adma.20160386410.1002/adma.201603864 ↗
15. 10.1039/C4MD00481G10.1039/C4MD00481G ↗
16. 10.1016/j.pdpdt.2018.03.00610.1016/j.pdpdt.2018.03.006 ↗
17. 10.1021/am500965n10.1021/am500965n ↗
18. 10.1021/nn501073x10.1021/nn501073x ↗
19. 10.1021/acsami.7b0902510.1021/acsami.7b09025 ↗
20. 10.1039/C5PP00057B10.1039/C5PP00057B ↗
21. 10.1111/j.1751-1097.1997.tb01925.x10.1111/j.1751-1097.1997.tb01925.x ↗
22. 10.1021/ja075933a10.1021/ja075933a ↗
23. 10.1016/j.snb.2017.01.00810.1016/j.snb.2017.01.008 ↗
24. 10.1246/bcsj.71.259710.1246/bcsj.71.2597 ↗
25. 10.1021/la051183b10.1021/la051183b ↗
26. 10.1021/jm400025g10.1021/jm400025g ↗
27. 10.1039/C5TB02563J10.1039/C5TB02563J ↗
28. 10.1021/jm401214210.1021/jm4012142 ↗
29. 10.1139/v95-20010.1139/v95-200 ↗
30. 10.1039/a802740d10.1039/a802740d ↗
31. 10.1021/acs.jchemed.5b0048310.1021/acs.jchemed.5b00483 ↗
32. 10.1021/j100550a01010.1021/j100550a010 ↗
33. 10.1021/acs.orglett.7b0041610.1021/acs.orglett.7b00416 ↗
34. 10.1021/acs.joc.6b0215210.1021/acs.joc.6b02152 ↗
35. 10.1039/b201081j10.1039/b201081j ↗
36. 10.1016/S1572-1000(05)00007-410.1016/S1572-1000(05)00007-4 ↗
37. 10.1021/jp071521c10.1021/jp071521c ↗
38. 10.1002/adhm.20170127210.1002/adhm.201701272 ↗
39. 10.1158/1078-0432.CCR-08-155810.1158/1078-0432.CCR-08-1558 ↗